New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NeuroSense Therapeutics Ltd.
NRSN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

25M

Biotechnology

Next Earning date - 26 Nov 2024

25M

Biotechnology

Next Earning date - 26 Nov 2024

1.27USD
Shape0.06 ( 4.96%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

20%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

45%

Quote Panel

Shape
Updated October 26, 2024
1W 15.45 % 1M -0.78 % 3M 64.72 % 1Y 186.68 %

Key Metrics

Shape
  • Market Cap

    24.73M


  • Shares Outstanding

    19.47M


  • Share in Float

    14.55M


  • Dividende

    0


  • Earning Date

    26 Nov 2024


  • Price Target

    1.27


  • Average Volume

    277112


  • Beta

    1.555


  • Range

    0.401-2.33


  • Industry

    Biotechnology


  • Website

    https://www.neurosense-tx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

-11.67x

P/B Ratio

-0.0

Debt/Equity

0.0%

Net Margin

$-0.7

EPS

How NRSN compares to sector?

P/E Ratio

Relative Strength

Shape

NRSN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.56

Shape-898%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.25
vs -0.01

Q4.22

arrow
arrow

N/A

-0.27
vs NA

Q1.23

arrow
arrow

N/A

NA
vs -0.24

Q2.23

arrow
arrow

N/A

-0.44
vs -0.31

Q3.23

arrow
arrow

+140%

0.1
vs -0.25

Q4.23

arrow
arrow

N/A

NA
vs -0.27

Q1.24

arrow
arrow

N/A

-0.16
vs NA

Q2.24

arrow
arrow

N/A

NA
vs -0.44

Q3.24

arrow
arrow

N/A

-0.11
vs 0.1

Q4.24

arrow
arrow

N/A

-0.08
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-34%

-0.34
vs -0.34

Q4.22

arrow
arrow

-53%

-0.53
vs -0.34

Q1.23

arrow
arrow

-132%

-1.32
vs -0.53

Q2.23

arrow
arrow

+338%

3.38
vs -1.32

Q3.23

arrow
arrow

-400%

-4.00
vs 3.38

Q4.23

arrow
arrow

+157%

1.57
vs -4.00

Q1.24

arrow
arrow

+77%

0.77
vs 1.57

Q2.24

arrow
arrow

+50%

0.5
vs 0.77

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

4

4
vs 7

-43%

Q4.22

arrow
arrow

5

5
vs 4

25%

Q1.23

arrow
arrow

5

5
vs 5

NA

Q2.23

arrow
arrow

6

6
vs 5

20%

Q3.23

arrow
arrow

5

5
vs 6

-17%

Q4.23

arrow
arrow

8

8
vs 5

60%

Q1.24

arrow
arrow

8

8
vs 8

NA

Q2.24

arrow
arrow

7

7
vs 8

-12%

Earnings Growth

Latest News